TriSalus Life Sciences, Inc. TLSI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.9M-32.6% | $13.21M+14.2% | $11.57M+3.1% | $11.21M+22.3% | $9.17M+11.0% | ||
| $1.23M-30.2% | $1.76M-7.6% | $1.91M+5.8% | $1.8M+20.5% | $1.5M+22.9% | ||
| $7.67M-33.0% | $11.44M+18.5% | $9.66M+2.6% | $9.41M+22.7% | $7.67M+8.9% | ||
| 86.2%-0.5pp | 86.7%+3.1pp | 83.5%-0.4pp | 83.9%+0.2pp | 83.7%-1.6pp | ||
| $3.22M+25.1% | $2.57M-50.3% | $5.18M+31.9% | $3.92M+29.9% | $3.02M+2.1% | ||
| $7.41M-7.0% | $7.97M+16.6% | $6.84M-4.5% | $7.16M+6.4% | $6.73M-3.9% | ||
| $5.45M+30.7% | $4.17M-37.4% | $6.66M+17.7% | $5.66M+7.8% | $5.25M+12.7% | ||
| -$8.41M-157% | -$3.27M+63.7% | -$9.01M-22.9% | -$7.33M0.0% | -$7.33M+3.3% | ||
| -94.5%-69.7pp | -24.8%+53.2pp | -77.9%-12.5pp | -65.4%+14.6pp | -79.9%+11.8pp | ||
| $1.44M-1.1% | $1.45M-0.5% | $1.46M+2.6% | $1.42M+17.7% | $1.21M+13.2% | ||
| -$76K-7.0% | -$71K+24.5% | -$94K-135% | -$40K+84.1% | -$251K-146% | ||
| $1.54M+116% | -$9.75M+9.7% | -$10.81M-30.3% | -$8.29M+20.0% | -$10.37M-2.6% | ||
| $4K— | $0-100% | $5K+267% | -$3K-160% | $5K— | ||
| $1.54M+116% | -$9.75M+9.8% | -$10.81M-30.4% | -$8.29M+20.1% | -$10.38M-2.6% | ||
| 17.3%+91.2pp | -73.9%+19.6pp | -93.5%-19.6pp | -73.9%+39.3pp | -113.2%+9.2pp | ||
| $0.03+125% | -$0.12+87.5% | -$0.96-256% | -$0.27+30.8% | -$0.39+2.5% | ||
| -$8.28M-163% | -$3.15M+64.5% | -$8.85M-23.5% | -$7.17M-0.1% | -$7.16M+3.1% | ||
| -93%-69.2pp | -23.8%+52.7pp | -76.5%-12.6pp | -63.9%+14.2pp | -78.1%+11.3pp | ||
| -$8.41M-157% | -$3.27M+63.7% | -$9.01M-22.9% | -$7.33M0.0% | -$7.33M+3.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is TriSalus Life Sciences, Inc.'s revenue?
- TriSalus Life Sciences, Inc. (TLSI) generated $44.9M in revenue over the trailing twelve months, up 39.6% year over year.
- Is TriSalus Life Sciences, Inc. profitable?
- TriSalus Life Sciences, Inc. is not currently profitable: it reported a net loss of $27.3M over the trailing twelve months, a -60.9% net margin.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- Gross margin is 85.1% and operating margin is -62.4%, with a -60.9% net margin.
- What is TriSalus Life Sciences, Inc.'s earnings per share?
- TriSalus Life Sciences, Inc.'s diluted EPS over the trailing twelve months is $-1.32.
- Where does TriSalus Life Sciences, Inc.'s income statement data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
